Evolutionary Dynamics in Carcinogenesis and Response to Therapy
March 12-15, 2020
Westin Denver Downtown
Notice of Postponement
Last updated March 6, 2020
The AACR is closely monitoring the continuing developments pertaining to the novel coronavirus. The safety and security of AACR conference attendees are our top priorities. After careful evaluation of currently available information, and a thorough consideration of all the factors essential to conduct a meeting, the AACR has determined that due to events beyond our control, it is in the best interest of all concerned to postpone the Special Conference on Evolutionary Dynamics in Carcinogenesis and Response to Therapy that was scheduled for March 12-15, in Denver, Colorado.
The information reviewed included U.S. Federal government’s enforcement of travel prohibitions and restrictions on international travelers to enter the U.S., and the imposition of travel restrictions issued by cancer centers, academic institutions, and pharmaceutical companies. All of these factors materially affect the viability of the programs for this conference, and the AACR has consequently made this difficult decision.
Please note that this decision applies to the Special Conference on Evolutionary Dynamics in Carcinogenesis and Response to Therapy and does not impact other planned AACR events.
We recognize that the new data, exchange of information, and opportunities for collaboration offered by this conference are highly valued by the cancer research community, and we are working to reschedule the conference as soon as possible.
Information on the rescheduled program will be sent by email once it is available. In the meantime, registrants should note the following:
- All conference registrations will be refunded by April 17.
- For registrants that have a room reservation at the Westin Denver Downtown, cancellations will be accepted at no charge 72 hours in advance of the scheduled check-in date; registrants should contact the hotel at (303) 572-9100 to cancel their reservations.
- Many airlines have adjusted their rebooking and cancellation policies in response to the novel coronavirus situation. Registrants should contact their airlines or booking agents directly to cancel their travel to Denver.
- Abstracts that were scheduled to be presented as posters or short talks at the conference will not be published. Abstract authors are encouraged to submit an updated abstract once the rescheduled conference has been confirmed and abstract submission opens.
- Registrants who have questions can contact the AACR by email at email@example.com.
James DeGregori, University of Colorado, Aurora, Colorado
Marco Gerlinger, The Institute of Cancer Research, London, United Kingdom
Robert Gillies, Moffitt Cancer Center, Tampa, Florida
Andriy Marusyk, Moffitt Cancer Center, Tampa, Florida
- Watch this video from Conference Cochair James DeGregori:
This will mark the first AACR Special Conference on evolutionary dynamics in cancer and how these processes contribute to therapy resistance and failure. Tumors are genetically diverse and complex ecosystems that evolve in response to selection pressures from their environment. The aim of this AACR Special Conference is to move away from the simplistic view of cancer evolution as a merely genetic phenomenon and to discuss instead how microenvironmental, immune cell, genetic and epigenetic heterogeneity interact and evolve and how this influences cancer progression and therapy success or failure. By promoting the exchange of novel ideas and information between basic scientists, physicians, and other health professionals, this inaugural conference will enhance the understanding of cancer evolution and make progress toward treatment paradigms that limit therapy resistance.
PROFESSIONAL EDUCATIONAL GRANTS
Funding for this conference was made possible, in part, by National Cancer Institute of the National Institutes of Health under Award Number R13CA243226. The content and views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available